Antimicrobial resistance - Microorganisms
have evolved in the presence of antibiotics, which are
antimicrobial agents produced naturally by bacteria and
fungi. They have therefore developed multiple
resistance mechanisms (categorised in Fig. 6.14) to all classes
of antimicrobial agent (antibiotics and their derivatives). Resistance may be an innate property of a microorganism
(intrinsic resistance) or may be acquired, by either
spontaneous mutation or horizontal transfer of genetic
material from another organism. For some agents, e.g.
penicillins, a degree of resistance occurs in vivo when the bacterial load is high and the molecular target for the antimicrobial is down-regulated (an ‘inoculum effect’).
Antimicrobial Resistance |
The mecA gene encodes a low-affinity
penicillin-binding protein, which
confers resistance to meticillin and other
penicillinase-resistant penicillins in Staph. aureus. It is common for plasmids to
encode resistance to multiple
antimicrobials, which may be transferred horizontally. Extended spectrum â-lactamases (ESBL) are encoded on
plasmids, which are transferred relatively easily between
bacteria including Enterobacteriaceae. Plasmid-mediated
carbapenemases have been
detected in strains of Klebsiella pneumoniae. Glycopeptide
resistance in enterococci
is also transferred on mobile genetic
elements. Strains of MRSA have been described that exhibit
intermediate resistance to glycopeptides, through the
development of a relatively impermeable cell wall
(GISA).
Factors
implicated in the emergence of antimicrobialresistance
include the inappropriate use of antibiotics
when not indicated (e.g. in viral infections) inadequate
dosage or treatment duration, excessive use
of broad- spectrum
agents, and use of antimicrobials
as growth-promoters in agriculture. However any antimicrobial use exerts a
selection pressure that
favours the development of resistance. Combination
antimicrobial therapy may reduce the emergence
of resistance. This is recommended in treatment of
patients infected with HIV, which is highly prone
to spontaneous mutation (p. 406).
Despite use of
combination therapy for M. tuberculosis, multidrug-resistant
TB (MDR-TB, resistant to isoniazid and rifampicin)
and extremely drug-resistant TB (XDR-TB, resistant to isoniazid and rifampicin, any fluoroquinolone, and at least
one injectable antimicrobial antituberculous
agent) have been reported worldwide and are increasing in incidence
(p. 693).